How will Meta's nuclear deal impact AI energy use?
Why did Nvidia regain title as top valued company?
What effect will Trump's steel and aluminum tariffs have?
How is South Korea's new president shaping trade policy?
Why are auto makers concerned about China's mineral export curbs?
What caused CrowdStrike's revenue forecast to weaken?
How are US job openings rising amid trade tensions?
Breakthrough in Chronic Rhinosinusitis: Lyra's Phase 3 Trial Achieves Statistical Significance, FDA Path Ahead
stocktitan.net/news/LYRA/lyra-therapeutics-reports-positive-results-from-the-enlighten-2-jlamy2v6qyoz.html
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
- Met primary endpoint with statistically significant improvement…
This story appeared on stocktitan.net, 2025-06-02 15:23:16.193000.